
GB40401
UR 1102
Also known as (3,5-dibromo-4-hydroxyphenyl)-(2,3-dihydropyrido[4,3-b][1,4]oxazin-4-yl)methanone
Inhibitor of the renal urate transporter URAT1 with high selectivity to URAT1 over OAT1 and OAT3 in vitro (Ki values 0·057 µM, 7·2 µM, and 2·4 µM, respectively), capable of increasing the fractional excretion of urinary uric acid, and reducing plasma uric acid more effectively than Benzbromarone· A potential novel therapeutic option with an enhanced pharmacokinetic profile for patients with gout or hyperuricemia
ChemicalCAS1198153-15-9MW414.05FormulaC14H10Br2N2O3
- CAS number
- 1198153-15-9
- Molecular weight
- 414.05
- Formula
- C14H10Br2N2O3
- Solubility
- DMSO : 100 mg/mL (241·52 mM; Need ultrasonic)
- InChIKey
- ZMVGQIIOXCGAFV-UHFFFAOYSA-N
- Catalogue number
- GB40401
- Brand
- GLPBIO
Computed properties PubChem CID 44608229 · XLogP 2.6 · TPSA 62.7 Ų · H-bond donors 1
- XLogP
- 2.6
- TPSA
- 62.7 Ų
- H-bond donors
- 1
- H-bond acceptors
- 4
- Rotatable bonds
- 1
- Heavy atoms
- 21
SMILES C1COC2=C(N1C(=O)C3=CC(=C(C(=C3)Br)O)Br)C=NC=C2
Computed descriptors from PubChem (CID 44608229), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il